Nuwellis(NASDAQ) CHFS

Current PriceN/A

Market CapN/A

Since IPO (2012)-100%

5 Year-100%

1 Year-100%

1 Month-34%

Nuwellis last closing stock price
Metric	Price	Date
Last close	USD 2.05	2026-07-24

Nuwellis stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-28.07%	USD 2.85	2026-07-17
1 month	-34.19%	USD 3.12	2026-06-24
3 month	-95.04%	USD 41.30	2026-04-24
Year to date	-96.63%	USD 60.90	2025-12-31
1 year	-99.55%	USD 455.00	2025-07-24
3 year	-100%	USD 136,599.75	2023-07-25
5 year	-100%	USD 23,152,500.00	2021-07-23
Since inception	-100%	USD 10,905,454,545.45	2012-02-16

Nuwellis Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$8.77

Net Income (TTM)

-$19.05

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

N/A

CHFS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nuwellis

Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

CEO

John L. Erb

Website

www.nuwellis.com/patients

CHFS Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

N/A

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Payout Ratio

N/A

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Nuwellis Performance Analysis

Nuwellis annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	USD 8,543,000	7.9%
2023	2023-12-31	USD 8,864,000	3.8%
2024	2024-12-31	USD 8,740,000	-1.4%
2025	2025-12-31	USD 8,270,000	-5.4%

Nuwellis annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	USD -4,294,892.18	-70.7%
2023	2023-12-31	USD -592,626.31	-86.2%
2024	2024-12-31	USD -11,766.63	-98.0%
2025	2025-12-31	USD -888.36	-92.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$2.40

+1.3%

Gross Profit

$1.68

+1.6%

Gross Margin

70.08%

+1.3%

Market Cap

N/A

Market Cap/Employee

$0.07

N/A

Employees

N/A

Net Income

-$4.54

+1.5%

EBITDA

-$4.53

+1.5%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$2.35

-23.0%

Total Debt

$0.27

+0.5%

Accounts Receivable

$1.56

+1.0%

Inventory

$1.78

+1.0%

Long Term Debt

$0.00

+0.0%

Short Term Debt

$0.27

+1.1%

Return on Assets

-272.76%

+1.9%

Return on Invested Capital

-306.90%

+1.6%

Free Cash Flow

-$3.14

+1.2%

Operating Cash Flow

-$3.11

+1.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,411.98+0.00%

^DJIDJI

^DJIDJI$51,947.25+0.00%

^IXICNASDAQ

^IXICNASDAQ$24,975.82-0.01%

BTCBitcoin

BTCBitcoin$64,301.00+0.00%

SPCXSPCX

SPCXSPCX$114.87-0.03%

AAPLAAPL

AAPLAAPL$332.97+0.04%

AMZNAMZN

AMZNAMZN$232.11-0.01%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$9.10-0.06%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$7.42-0.04%

ONDSOndas

ONDSOndas$7.80-0.02%

FFord Motor Company

FFord Motor Company$14.37+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.48+0.07%

CLFCleveland-Cliffs

CLFCleveland-Cliffs$11.93+0.09%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$64.00-0.03%

Questions About CHFS

What is the current price of Nuwellis?

Nuwellis is trading at N/A per share.

What is the 52-week range for Nuwellis?

Over the past 52 weeks, Nuwellis has traded between N/A and N/A.

How much debt does Nuwellis have?

As of the most recent reporting period, Nuwellis reported total debt of $265.00K.

How much cash does Nuwellis have on hand?

Nuwellis reported $2.08M in cash and cash equivalents in its most recent financial results.

What is Nuwellis’s dividend yield?

Nuwellis does not currently have a dividend yield.

Nuwellis(NASDAQ) CHFS

Nuwellis Financials at a Glance

CHFS News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Nuwellis

CHFS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Nuwellis Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CHFS

What is the current price of Nuwellis?

What is the 52-week range for Nuwellis?

How much debt does Nuwellis have?

How much cash does Nuwellis have on hand?

What is Nuwellis’s dividend yield?

Premium Investing Services